KalVista Pharmaceuticals Inc (KALV)
12.49
+0.49
(+4.08%)
USD |
NASDAQ |
May 14, 16:00
12.52
+0.03
(+0.24%)
After-Hours: 20:00
KalVista Pharmaceuticals Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2020 | -172.2% |
| January 31, 2020 | -589.2% |
| October 31, 2019 | -150.6% |
| July 31, 2019 | -217.8% |
| April 30, 2019 | -291.4% |
| January 31, 2019 | -101.7% |
| October 31, 2018 | -59.08% |
| July 31, 2018 | -135.3% |
| April 30, 2018 | -13.57% |
| January 31, 2018 | -224.5% |
| October 31, 2017 | -442.4% |
| July 31, 2017 | -5.13K% |
| April 30, 2017 | -3.69K% |
| Date | Value |
|---|---|
| January 31, 2017 | -3.08K% |
| September 30, 2016 | -34.07K% |
| June 30, 2016 | -105.0K% |
| March 31, 2016 | -94.39K% |
| December 31, 2015 | -70.74K% |
| September 30, 2015 | -71.30K% |
| June 30, 2015 | -128.7K% |
| March 31, 2015 | -74.06K% |
| December 31, 2014 | -58.92K% |
| September 30, 2014 | -39.95K% |
| June 30, 2014 | -52.70K% |
| March 31, 2014 | -33.58K% |
| December 31, 2013 | -303.3% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-589.2%
Minimum
Jan 2020
-150.6%
Maximum
Oct 2019
-282.4%
Average
-195.0%
Median
Profit Margin (Quarterly) Benchmarks
| Haemonetics Corp | 9.29% |
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 10.76% |
| Xtant Medical Holdings Inc | -15.31% |
| Asensus Surgical Inc | -317.3% |